SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ALAB

Astera Labs, Inc. (NASDAQ:ALAB)

US · Delayed Price · Currency is USD
Technology · Semiconductors
259.51+2.35 (+0.91%)
 
Market cap
$45.0B
Health Score
Analyst consensus
Listed since
Mar 20, 2024
Insider Score
––Not scored
ALAB Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

ALAB analyst forecast

ALAB analyst consensus

Moderate Buy8 ratings
Buy 6 Hold 2 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

ALAB 12-month price target

No published price targets in the last 12 months.

Best analysts covering ALAB

  • Morgan Stanley100%success rate · 8 calls
  • Stifel100%success rate · 7 calls
  • Needham100%success rate · 6 calls
  • Evercore ISI Group100%success rate · 4 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

ALAB analyst ratings

FirmPrice targetAction
—TD CowenHold——Reiterated2026-10-19
—Northland Capital MarketsOutperform——Upgraded2026-08-17
—TD CowenHold——Reiterated2026-08-05
—RBC CapitalOutperform——Reiterated2026-08-05
—Morgan StanleyOverweight——Reiterated2026-08-05
—JefferiesBuy——Reiterated2026-08-05
—NeedhamBuy——Reiterated2026-08-05
—Evercore ISI GroupOutperform——Reiterated2026-08-05
—SusquehannaNeutral——Reiterated2026-07-31
—BarclaysEqual Weight——Reiterated2026-07-20
—TD CowenHold——Reiterated2026-07-13
—UBSNeutral——Reiterated2026-06-29
—StifelBuy——Reiterated2026-06-24
—B of A SecuritiesNeutral——Reiterated2026-06-23
—Evercore ISI GroupOutperform——Reiterated2026-05-19
—BarclaysEqual Weight——Reiterated2026-05-07
—TD CowenHold——Reiterated2026-05-06
—CitigroupBuy——Reiterated2026-05-06
—Morgan StanleyOverweight——Reiterated2026-05-06
—RBC CapitalOutperform——Reiterated2026-05-06
—SusquehannaNeutral——Reiterated2026-05-06
—StifelBuy——Reiterated2026-05-06
—NeedhamBuy——Reiterated2026-05-06
—JP MorganOverweight——Reiterated2026-05-06
—CitigroupBuy——Reiterated2026-04-02
—CitigroupBuy——Reiterated2026-02-11
—Northland Capital MarketsOutperform——Reiterated2025-12-09
—Northland Capital MarketsOutperform——Upgraded2025-11-17
—Roth CapitalBuy——Reiterated2025-11-05
—TD CowenHold——Reiterated2025-11-05
—Morgan StanleyOverweight——Reiterated2025-11-05
—NeedhamBuy——Reiterated2025-11-05
—StifelBuy——Reiterated2025-11-05
—JP MorganOverweight——Reiterated2025-11-05
—BarclaysEqual Weight——Downgraded2025-10-20
—StifelBuy——Reiterated2025-10-17
—CitigroupBuy——Reiterated2025-09-17
—Deutsche BankBuy——Reiterated2025-09-02
—Morgan StanleyOverweight——Reiterated2025-08-29
—SusquehannaNeutral——Reiterated2025-08-07
—BarclaysOverweight——Reiterated2025-08-07
—NeedhamBuy——Reiterated2025-08-06
—Evercore ISI GroupOutperform——Reiterated2025-08-06
—Morgan StanleyOverweight——Reiterated2025-08-06
—StifelBuy——Reiterated2025-08-04
—Morgan StanleyOverweight——Reiterated2025-07-30
—JefferiesBuy——Reiterated2025-07-22
—StifelBuy——Reiterated2025-07-18
—Evercore ISI GroupOutperform——Reiterated2025-05-21
—Morgan StanleyOverweight——Upgraded2025-05-12
—NeedhamBuy——Reiterated2025-05-07
—Morgan StanleyEqual Weight——Reiterated2025-05-07
—BarclaysOverweight——Reiterated2025-05-07
—StifelBuy——Reiterated2025-04-17
—CitigroupBuy——Reiterated2025-04-14
—Evercore ISI GroupOutperform——Reiterated2025-02-11
—Craig-HallumBuy——Reiterated2025-02-11
—NeedhamBuy——Reiterated2025-02-11
—Northland Capital MarketsOutperform——Upgraded2025-01-28
—Morgan StanleyEqual Weight——Reiterated2025-01-28

ALAB earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-02-100.520.58$249.5M$270.6M
2026-05-050.540.61$292.2M$308.4M
2026-08-040.690.80$360.9M$392.4M
2026-11-031.190.00$550.8M$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.